Svetlana Taycher, DO | |
831 Nw Council Dr, Suite 125, Gresham, OR 97030-3721 | |
(503) 661-3439 | |
(503) 669-1360 |
Full Name | Svetlana Taycher |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 23 Years |
Location | 831 Nw Council Dr, Gresham, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215992466 | NPI | - | NPPES |
022797 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | DO25271 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Adventist Health Home Care Services | Portland, OR | Home health agency |
Adventist Health Portland | Portland, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Portland Adventist Medical Center | 3274908819 | 221 |
News Archive
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
An international consortium of scientists led by a group from the University of Leicester has announced a new advance in understanding the mechanisms of cancer and how to target it more effectively with new treatments...
Most medications being tested today in clinical trials for the treatment of coronavirus disease 2019 (COVID-19) have been repurposed from other indications. These are typically not tested in pregnant women. A new study, published in the journal PLOS ONE, summarizes what is known about the safety of these drugs in this group.
› Verified 5 days ago
Entity Name | Portland Adventist Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215910302 PECOS PAC ID: 7012827876 Enrollment ID: O20040226000131 |
News Archive
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
An international consortium of scientists led by a group from the University of Leicester has announced a new advance in understanding the mechanisms of cancer and how to target it more effectively with new treatments...
Most medications being tested today in clinical trials for the treatment of coronavirus disease 2019 (COVID-19) have been repurposed from other indications. These are typically not tested in pregnant women. A new study, published in the journal PLOS ONE, summarizes what is known about the safety of these drugs in this group.
› Verified 5 days ago
Entity Name | Portland Adventist Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750091021 PECOS PAC ID: 3274908819 Enrollment ID: O20230412001327 |
News Archive
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
An international consortium of scientists led by a group from the University of Leicester has announced a new advance in understanding the mechanisms of cancer and how to target it more effectively with new treatments...
Most medications being tested today in clinical trials for the treatment of coronavirus disease 2019 (COVID-19) have been repurposed from other indications. These are typically not tested in pregnant women. A new study, published in the journal PLOS ONE, summarizes what is known about the safety of these drugs in this group.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Svetlana Taycher, DO Po Box 92900, Portland, OR 97292-0900 Ph: () - | Svetlana Taycher, DO 831 Nw Council Dr, Suite 125, Gresham, OR 97030-3721 Ph: (503) 661-3439 |
News Archive
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
An international consortium of scientists led by a group from the University of Leicester has announced a new advance in understanding the mechanisms of cancer and how to target it more effectively with new treatments...
Most medications being tested today in clinical trials for the treatment of coronavirus disease 2019 (COVID-19) have been repurposed from other indications. These are typically not tested in pregnant women. A new study, published in the journal PLOS ONE, summarizes what is known about the safety of these drugs in this group.
› Verified 5 days ago
Dr. Paul E Vanbredavriesman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 18000 Se Stark Street, Gresham, OR 97233 Phone: 503-255-4243 Fax: 503-255-4243 | |
Dr. Joseph Mark Eisenberg, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Ne 8th St, 3rd Floor, East County Health Center, Gresham, OR 97030 Phone: 503-988-5155 Fax: 503-988-5185 | |
Gordon Paul Canzler, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Ne Roberts Ave, Gresham, OR 97030 Phone: 503-665-9144 Fax: 503-665-6404 | |
Janet R Monnier, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 831 Nw Council Dr, Suite 101, Gresham, OR 97030 Phone: 503-665-8176 Fax: 503-665-8178 | |
Caroline Chase Adams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 440 Nw Division St, Gresham, OR 97030 Phone: 503-215-9525 | |
Paul Podett, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 24900 Se Stark St Ste 205, Gresham, OR 97030 Phone: 503-665-1010 Fax: 503-665-1023 |